Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Morelon

Showing results (161-170 of 209) with videos related to

Pageof 21
Sort By:
Transplantation|July 14, 2025
Identification of Donor-recipient Interactions for a Relative Appraisal of Kidney Graft Marginality: A French Multicentric Cohort-based StudyCorentin Choisy, Yohann Foucher, Christophe Masset, et al.
Kidney International|November 4, 2024
Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipientsSophie Caillard, Nicolas Meyer, Morgane Solis, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 29, 2025
Updates on Donor-Derived Infection in Solid Organ Transplantation, Report from the 2024 GTI (Infection and Transplantation Group) Annual MeetingCarole Eldin, Paolo Antonio Grossi, Victoria Manda, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 23, 2021
Cohort study: "Outcomes of kidney transplantation in patients with prosthetic heart valves"Hajar Ouahmi, Pamela Moceri, Kevin Zorzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2018
Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year ResultsJacques Dantal, Emmanuel Morelon, Lionel Rostaing, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 13, 2025
γδ T Cells' Role in Donor-Specific Antibody Generation: Insights From Transplant Recipients and Experimental ModelsXavier Charmetant, Guillaume Rigault, Chien-Chia Chen, et al.
The New England Journal of Medicine|July 27, 2012
Sirolimus and secondary skin-cancer prevention in kidney transplantationSylvie Euvrard, Emmanuel Morelon, Lionel Rostaing, et al.
Transplantation|September 20, 2011
Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL networkSophie Borot, Nadja Niclauss, Anne Wojtusciszyn, et al.
Frontiers in Immunology|May 25, 2026
The risk of venous thromboembolism in kidney transplant recipients is enhanced following a cytomegalovirus infectionChristophe Masset, Marine Lorent, Florent Le Borgne, et al.
Science Translational Medicine|February 1, 2022
Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipientsXavier Charmetant, Maxime Espi, Ilies Benotmane, et al.
Pageof 21

Showing results (161-170 of 209) with videos related to

Sort By:
Pageof 21
Transplantation|July 14, 2025
Identification of Donor-recipient Interactions for a Relative Appraisal of Kidney Graft Marginality: A French Multicentric Cohort-based StudyCorentin Choisy, Yohann Foucher, Christophe Masset, et al.
Kidney International|November 4, 2024
Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipientsSophie Caillard, Nicolas Meyer, Morgane Solis, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 29, 2025
Updates on Donor-Derived Infection in Solid Organ Transplantation, Report from the 2024 GTI (Infection and Transplantation Group) Annual MeetingCarole Eldin, Paolo Antonio Grossi, Victoria Manda, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 23, 2021
Cohort study: "Outcomes of kidney transplantation in patients with prosthetic heart valves"Hajar Ouahmi, Pamela Moceri, Kevin Zorzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2018
Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year ResultsJacques Dantal, Emmanuel Morelon, Lionel Rostaing, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 13, 2025
γδ T Cells' Role in Donor-Specific Antibody Generation: Insights From Transplant Recipients and Experimental ModelsXavier Charmetant, Guillaume Rigault, Chien-Chia Chen, et al.
The New England Journal of Medicine|July 27, 2012
Sirolimus and secondary skin-cancer prevention in kidney transplantationSylvie Euvrard, Emmanuel Morelon, Lionel Rostaing, et al.
Transplantation|September 20, 2011
Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL networkSophie Borot, Nadja Niclauss, Anne Wojtusciszyn, et al.
Frontiers in Immunology|May 25, 2026
The risk of venous thromboembolism in kidney transplant recipients is enhanced following a cytomegalovirus infectionChristophe Masset, Marine Lorent, Florent Le Borgne, et al.
Science Translational Medicine|February 1, 2022
Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipientsXavier Charmetant, Maxime Espi, Ilies Benotmane, et al.
Pageof 21